Establishing secure connection…Loading editor…Preparing document…

Research License Agreement

This template is fully customizable. Edit the text, fill out the fields, and send it for signature. Give it a try!

RESEARCH LICENSE AGREEMENT

This Research License Agreement ("Agreement") is entered into as of by and between Licensor Name: and Licensee Name: .

WHEREAS

WHEREAS, Licensor is the sole legal owner of certain research materials, data, know-how, protocols, and associated documentation identified herein as Licensed Materials; and

WHEREAS, Licensee desires to obtain, and Licensor is willing to grant, a license to use the Licensed Materials for non-commercial research activities under the terms and conditions set forth in this Agreement.

WHEREAS, the parties intend to establish a limited scope of permitted use, protection of confidential information, and allocation of rights in improvements and data.

SCOPE OF WORK / LICENSED MATERIALS

Licensor hereby grants to Licensee a Non-Exclusive , Exclusive , or Limited Term license (select applicable) to use the Licensed Materials solely for the research purpose described above ("Permitted Purpose"). The license is non-transferable and non-sublicensable except as expressly provided in this Agreement.

PAYMENT TERMS

License Fee: Licensee shall pay Licensor a license fee of $ payable in accordance with the schedule below. All amounts are exclusive of taxes; Licensee is responsible for applicable taxes.

Late Payment: Any undisputed overdue amount shall bear interest at the lesser of 1.5% per month or the maximum rate permitted by applicable law. Licensee shall also reimburse Licensor for reasonable collection costs and attorneys' fees incurred in collecting overdue payments.

TERM AND TERMINATION

Term: The term of this Agreement shall commence on and, unless earlier terminated in accordance with this Agreement, shall expire on .

Termination for Cause: Either party may terminate this Agreement upon written notice if the other party materially breaches any term and fails to cure such breach within days after receipt of written notice specifying the breach.

Effect of Termination: Upon termination or expiration, Licensee shall cease all use of Licensed Materials, return or destroy Confidential Information as directed, and certify compliance in writing within thirty (30) days.

CONFIDENTIALITY

Definition: "Confidential Information" means non-public information disclosed by one party to the other in connection with this Agreement, including proprietary data, protocols, and unpublished results, whether oral, written, or electronic.

Obligations: The receiving party shall: (a) use Confidential Information solely for the Permitted Purpose; (b) protect Confidential Information with at least the same degree of care it uses to protect its own confidential information but no less than reasonable care; and (c) not disclose Confidential Information to any third party except to its employees or authorized contractors who have a need to know and are bound by confidentiality obligations at least as protective as those herein.

Exceptions: Confidential Information does not include information that: (a) is or becomes publicly available other than by breach of this Agreement; (b) is rightfully received from a third party without restriction; (c) is independently developed without reference to Confidential Information; or (d) is required to be disclosed by law, provided the disclosing party is given prompt written notice and an opportunity to seek protective measures.

INTELLECTUAL PROPERTY; IMPROVEMENTS

Ownership: Licensor retains all right, title and interest in and to the Licensed Materials and all intellectual property rights therein. Licensee acquires only the rights expressly granted in this Agreement.

Improvements: Any improvements, modifications or derivatives to the Licensed Materials conceived or developed by Licensee in the course of performing activities under this Agreement shall be Assigned to Licensor Licensed to Licensor Retained by Licensee (subject to a license to Licensor).

USE RESTRICTIONS; COMPLIANCE

Licensee shall not use the Licensed Materials for commercial product development, clinical trials, human administration outside specified research contexts, or any use that would infringe third-party rights. Licensee shall comply with all applicable laws, regulations, and institutional policies in its use of the Licensed Materials.

INDEMNIFICATION; LIMITATION OF LIABILITY

Indemnification: Licensee shall indemnify, defend and hold harmless Licensor and its officers, agents and employees from and against third-party claims arising out of Licensee's negligent or willful use of the Licensed Materials, breach of this Agreement, or violation of law.

Limitation of Liability: Except for willful misconduct or gross negligence, in no event shall either party be liable for consequential, incidental, special or punitive damages, and each party's aggregate liability for claims arising under this Agreement shall not exceed the fees paid by Licensee to Licensor under this Agreement during the twelve (12) month period preceding the claim.

NOTICES

GOVERNING LAW; MISCELLANEOUS

Governing Law: This Agreement shall be governed by and construed in accordance with the laws of the State of without regard to conflict of laws principles. The parties submit to the exclusive jurisdiction of the courts located in that State for disputes arising under this Agreement.

Amendment: Any amendment or modification of this Agreement must be in writing and signed by authorized representatives of both parties to be effective.

Assignment: Neither party may assign or transfer this Agreement or any rights hereunder without the prior written consent of the other party, except that Licensor may assign to an affiliate or successor in interest.

ENTIRE AGREEMENT

This Agreement, including all schedules and exhibits furnished hereunder, constitutes the entire agreement between the parties with respect to the subject matter and supersedes all prior and contemporaneous agreements, proposals and understandings, whether written or oral.

Licensor Printed Name:

By:

Date:

Licensee Printed Name:

By:

Date:

Enter text✕
Prepare your document for signing right on this page
  • 01 Edit the text and complete the fields
  • 02 Click Sign Now and on the next screen add recipients and signature fields in SignNow
  • 03 Start your free trial to sign and send your doc
Sign Now

What a Research License Agreement Covers

A Research License Agreement is a legal contract that grants permission to use specified research materials, data, inventions, or intellectual property for defined purposes, duration, and territory. It sets the scope of permitted use, ownership of improvements, confidentiality obligations, publication and attribution rights, and payment or consideration terms. Parties frequently include baseline warranties, indemnities, termination conditions, and dispute-resolution provisions. For electronic execution, the agreement should satisfy ESIGN (15 U.S.C. ch. 96) and applicable state UETA provisions to ensure enforceability across U.S. jurisdictions and to document intent, attribution, consent, and retention.

Why a Clear Research License Agreement Matters

A well-drafted agreement reduces ambiguity about data use, prevents IP disputes, preserves publication rights, and allocates liability. It also clarifies regulatory obligations for controlled data and supports enforceability when signed electronically under ESIGN and UETA frameworks.

Why a Clear Research License Agreement Matters

Who Typically Prepares or Signs This Agreement

Organizations and individuals who create, share, or fund research frequently need a formal license to control use, attribution, and downstream rights.

  • Academic institutions and research offices: university tech transfer or sponsored-research offices handling IP assignments and material-transfer terms.
  • Commercial labs and startups: companies licensing university technology or sharing proprietary datasets under controlled terms.
  • Government labs and funders: agencies defining permitted uses, publication rules, and data-sharing restrictions tied to grant funding.

Signatories typically include an authorized representative for the licensor, an authorized representative for the licensee, and occasionally institutional counsel or a grants officer to approve terms.

Core Sections Every Professional Agreement Should Include

A complete Research License Agreement organizes the parties, the licensed subject matter, limits on use, and the lifecycle of rights clearly to reduce disputes and support compliance with funding or regulatory requirements.

Parties

Identify legal entity names, business types, and authorized signers to avoid later identity or enforcement problems.

Licensed Subject

Describe data, materials, software, or IP with precision, including version, accession numbers, or file identifiers as applicable.

Scope of Use

Set permitted activities (research only, commercial rights excluded), geographic limits, sublicensing rules, and publication permissions.

Term and Termination

Specify effective date, duration, renewal options, and events that permit termination or survival of key clauses.

IP and Improvements

Allocate ownership of preexisting IP, jointly created improvements, and procedures for patenting or commercialization.

Confidentiality & Compliance

Detail confidentiality obligations, data protection controls, regulatory constraints (HIPAA, FERPA), and reporting duties for breaches.

Stepwise Completion and Execution Process

Follow these sequential steps to prepare, review, and finalize a Research License Agreement with minimal rework and legal exposure.

  • 01
    Draft Core Terms: Populate parties, licensed materials, scope, term, and payment in a single draft before sending for review.
  • 02
    Internal Review: Have institutional counsel or tech-transfer confirm IP allocation, indemnity, and export-control language.
  • 03
    Signatory Authority: Verify signers have corporate authority or board delegation to bind the party; otherwise, obtain a written delegation.
  • 04
    Execute and Retain: Collect signatures, save a complete executed copy, and distribute to stakeholders with version and access controls.

Execution Workflow and Document Routing

A typical electronic workflow moves the agreement from drafter to approvers, then to authorized signers, and finally into secure storage with an audit trail.

  • Prepare Document: Upload final PDF or DOCX, mark signature and date fields, and embed any mandatory disclosures.
  • Assign Reviewers: Route to counsel or grants office for required approvals before sending to external signers.
  • Request Signatures: Send signing requests in the agreed order with signer authentication measures appropriate to risk.
  • Archive Execution: Store executed copy and certificate of completion in the contract repository and with research records.

Recommended Digital Workflow Settings

Configure your signing workflow to match institutional review and authentication needs; these settings balance security and signer convenience.

Field Configuration
Authentication Type Email link | Optional SMS code or KBA for higher risk
Routing Order Sequential | Enforce legal ordering for authorized signers
Signature Type Electronic signature | Use PKI/digital if non-repudiation required
Storage Location Institutional contract repository | Cloud-signed PDF kept with audit trail

Technical Considerations for eSigning and eSubmission

Choose a platform that supports required authentication, audit trails, and the file formats your organization uses.

  • Integrations: Salesforce, NetSuite, Google Workspace, Microsoft 365
  • File Formats: PDF, DOCX, HTML, Excel supported
  • Security Controls: TLS 1.2/1.3, AES-256 at rest

Ensure the platform supports export of a tamper-evident PDF with an audit trail and meets any industry-specific compliance requirements before use.

Typical eSignature Pricing and Feature Comparison

Compare common pricing and feature dimensions for eSignature vendors used to execute Research License Agreements; signNow is listed first per table convention.

signNow DocuSign Adobe Sign PandaDoc HelloSign
Starting Price $8/user/mo $15/user/mo $14/user/mo $19/user/mo $15/user/mo
Free Trial 7-day free trial Trial varies Trial varies Trial varies Trial varies
Bulk Send Yes Yes Yes Yes No
Audit Trail Yes Yes Yes Yes Yes
HIPAA Compliant Yes Yes Yes No No
Envelope Cap No cap 100 envelopes/user/year Varies by plan Varies by plan Varies by plan

Security and Compliance Controls to Verify

Encryption: TLS 1.2/1.3 in transit; AES-256 at rest
HIPAA: BAA available for protected health information
ESIGN / UETA: Compliant with ESIGN and UETA frameworks
SOC 2: SOC 2 Type II certification available
21 CFR Part 11: Controls for FDA-regulated records supported
Accessibility: WCAG 2.0 Level AA compliance

Potential Penalties and Legal Risks to Watch

Tax Reporting Risk: Incorrect TINs may trigger backup withholding at 24%
Contract Voidance: Missing authority or material ambiguity can render agreement unenforceable
Data Breach Liability: Failure to secure controlled data may trigger HIPAA or contractual penalties
I-9 Noncompliance: Employment verification errors carry DHS fines
Intentional Misreporting: Deliberate false filings can incur steep IRC §6721 penalties
Export Controls: Unauthorized transfers of controlled technology risk sanctions

Common Preparation Errors to Avoid

  • Vague licensed-material descriptions that omit versions, file identifiers, or accession numbers and result in downstream disputes over scope and deliverables.
  • Failing to confirm signatory authority or relying on informal signatures which can leave the agreement subject to challenge during enforcement or audit.
  • Neglecting export-control, privacy, or sponsor-imposed restrictions that prohibit certain transfers or require additional approvals and compliance steps.
  • Using inconsistent party names or mismatched entity identifiers across schedules, exhibits, and signature blocks, which complicates tax and payment processing.

Realistic Use Cases for a Research License Agreement

These concise case sketches show common scenarios where a Research License Agreement clarifies rights, responsibilities, and downstream commercialization pathways.

University to Startup

A university licenses a prototype dataset to a startup for internal algorithm development

  • The startup may not commercialize outputs absent a separate commercialization license
  • The agreement sets milestone payments, publication review periods, and IP ownership for jointly created improvements to avoid future disputes and preserve sponsor reporting compliance.

Cross-Institution Collaboration

Two labs share annotated clinical datasets for joint research under a limited-use license

  • Each party agrees to de-identification and HIPAA safeguards
  • The license specifies permitted analyses, publication authorship order, data destruction timing, and procedures for handling breach notifications to sponsors and affected subjects.

How a Research License Agreement Differs from Related Documents

Contrast common document types to identify when a research license is appropriate versus other agreements such as NDAs, Material Transfer Agreements (MTAs), or consulting contracts.

Document Type Primary Purpose Typical IP Outcome
Research License permit research use licensor retains title; licensee gets usage rights
MTA transfer physical materials often limits redistribution; may restrict commercialization
NDA protect confidential information no license to use ip; confidentiality only
Consulting Agreement define services and deliverables ip often assigned to client by clause

Frequently Asked Questions About Execution and Validity

Answers address common legal and procedural questions about signing, notarization, revocation, and recordkeeping for Research License Agreements.


Need help? Contact support

be ready to get more
Join over 28 million airSlate SignNow users
Sign Now
Company
Forms
Pricing
Resources
Knowledge base
Other Products
© 2026 airSlate Inc. All rights reserved.